• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $APP

    Applovin Corporation

    Subscribe to $APP
    $APP
    Computer Software: Programming Data Processing
    Technology

    AppLovin Corporation engages in building a software-based platform for mobile app developers to enhance the marketing and monetization of their apps worldwide. The company's software solutions include AppDiscovery, a solution to automate, optimize, and manage user acquisition investments for business clients; and MAX, an in-app bidding solution that optimizes purchases of app ad inventory. Its business clients include various advertisers, internet platforms, and others. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

    IPO Year: 2021

    Exchange: NASDAQ

    Website: applovin.com

    Recent Analyst Ratings for Applovin Corporation

    DatePrice TargetRatingAnalyst
    4/10/2025$350.00Equal-Weight → Overweight
    Morgan Stanley
    3/28/2025$385.00Outperform
    FBN Securities
    1/10/2025$375.00Buy
    The Benchmark Company
    11/20/2024$400.00Overweight
    Piper Sandler
    11/8/2024$80.00 → $280.00Neutral → Outperform
    Daiwa Securities
    10/29/2024$200.00Overweight
    Wells Fargo
    10/22/2024$181.00Buy
    Loop Capital
    10/14/2024$103.00 → $150.00Buy → Neutral
    Goldman
    9/17/2024$100.00 → $145.00Neutral → Buy
    UBS
    5/2/2024$70.00 → $93.00Buy
    Jefferies
    See more ratings